IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

Arun has over 15 years’ experience covering the Technology sector. During this time, he has worked with technology start-ups and as an equity analyst in investment banks and independent research firms. He was formerly a Technology Analyst for Canaccord Genuity, Altium Securities, Espirito Santo Investment Bank, Noble Group and Clear Capital. He has a dual Master’s degree in Financial Engineering and Industrial and Operations Engineering from the University of Michigan. He obtained his Bachelor’s degree in Mechanical Engineering from the Indian Institute of Technology, Bombay. He is also a CFA charterholder.

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Equity Capital Markets

Angelalign Technology  / Equity Capital Markets

<p><a href="https://www.smartkarma.com/entities/angelalign-technology-inc" target="_blank" data-smartkarma-citation="entities:31480:1" rel="noopener">Angelalign Technology (AAT HK)</a> is a leading clear aligner treatment solution provider in China. It is the second-largest player accounting for 41.0% market share in 2020 as measured by case shipments, according to CIC. Angelalign is pre-marketing an HKEx IPO to raise $300 million, according to press reports. </p><p>China’s clear aligner market, which is the second-largest in the world as measured by retail sales revenue, is forecasted to grow from $1.5 billion in 2020 to $11.9 billion in 2030 at a CAGR of 23.1%, according to CIC. The growth is driven by consumers increased readiness to receive treatment as clear aligners have improved aesthetics during treatment and the expanding addressable indications as clear aligners provide greater control of teeth movement.</p><div class="content-highlight"><p>Angelalign is ideally positioned to benefit from this market opportunity due to high market share, strong growth, rising margins and prodigious cash generation. Overall, we believe that Angelalign is worth a look.</p></div>

Angelalign Technology (AAT HK) is a leading clear aligner treatment solution provider in China. It is the second-largest player accounting for 41.0% market share in 2020 as measured by case shipments, according to CIC. Angelalign is pre-marketing an HKEx IPO to raise $300 million, according to press reports. China’s clear aligner market, which is the second-largest in the world as measured by retail sales revenue, is forecasted to grow from $1.5 billion in 2020 to $11.9 billion in 2030 at a CAGR of 23.1%, according to CIC. The growth is driven by consumers increased readiness to receive treatment as clear aligners have improved aesthetics during treatment and the expanding addressable indications as clear aligners provide greater control of teeth movement.Angelalign is ideally positioned to benefit from this market opportunity due to high market share, strong growth, rising margins and prodigious cash generation. Overall, we believe that Angelalign is worth a look.

Angelalign IPO Initiation: If Tooth Be Told